Diagnostic enteral gastrointestinal radiopaque human prescription drugs class labeling guideline for professional labeling. Final report
Abstract
The Food and Drug Administration (FDA) announces the availability of a class labeling guideline for the professional labeling of diagnostic enteral gastrointestinal radiopaque agents. Class labeling is appropriate for these products because they are all closely related in chemical structure, pharmacology, therapeutic activity, and adverse reactions. The guideline is intended to promote the use of identical professional labeling for each member of the diagnostic enteral gastrointestinal radiopaque drug class.
- Authors:
- Publication Date:
- Research Org.:
- National Center for Drugs and Biologics, Rockville, MD (USA)
- OSTI Identifier:
- 5504711
- Report Number(s):
- PB-83-251041
- Resource Type:
- Technical Report
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 62 RADIOLOGY AND NUCLEAR MEDICINE; CONTRAST MEDIA; LABELLING; STANDARDS; DRUGS; GASTROINTESTINAL TRACT; DIGESTIVE SYSTEM; 550601* - Medicine- Unsealed Radionuclides in Diagnostics
Citation Formats
Chun, M Y. Diagnostic enteral gastrointestinal radiopaque human prescription drugs class labeling guideline for professional labeling. Final report. United States: N. p., 1982.
Web.
Chun, M Y. Diagnostic enteral gastrointestinal radiopaque human prescription drugs class labeling guideline for professional labeling. Final report. United States.
Chun, M Y. 1982.
"Diagnostic enteral gastrointestinal radiopaque human prescription drugs class labeling guideline for professional labeling. Final report". United States.
@article{osti_5504711,
title = {Diagnostic enteral gastrointestinal radiopaque human prescription drugs class labeling guideline for professional labeling. Final report},
author = {Chun, M Y},
abstractNote = {The Food and Drug Administration (FDA) announces the availability of a class labeling guideline for the professional labeling of diagnostic enteral gastrointestinal radiopaque agents. Class labeling is appropriate for these products because they are all closely related in chemical structure, pharmacology, therapeutic activity, and adverse reactions. The guideline is intended to promote the use of identical professional labeling for each member of the diagnostic enteral gastrointestinal radiopaque drug class.},
doi = {},
url = {https://www.osti.gov/biblio/5504711},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Tue Sep 21 00:00:00 EDT 1982},
month = {Tue Sep 21 00:00:00 EDT 1982}
}
Other availability
Please see Document Availability for additional information on obtaining the full-text document. Library patrons may search WorldCat to identify libraries that may hold this item. Keep in mind that many technical reports are not cataloged in WorldCat.
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.